Tauriga Sciences Appoints Robert Millman JD to Business Advisory Board

Tauriga Sciences Inc. (OTCQB:TAUG) a diversified life sciences company which currently holds a pending acquisition in the cannabis space, has appointed Robert Millman, JD to its business advisory board. Mr. Millman will focus introducing Tauriga to additional institutional investors and on evaluating opportunities for the company in the life sciences space.

As quoted in the press release:

Mr. Millman is an experienced portfolio manager focused on growth businesses in the biotechnology, specialty pharma, and medical technologies spaces. He currently serves as a Managing Director of the prestigious life sciences fund MPM Capital  and is also an experienced IP (“patent”) attorney. Mr. Millman is contributing his considerable individual expertise and is not representing MPM Capital in his capacity as a Business Advisory Member. Moreover, he has personally invested in Tauriga Sciences based on his confidence in their strategic plan. With this appointment of Mr. Millman, Tauriga’s business advisory board is now comprised of eight highly qualified members.

Tauriga CEO, Dr. Stella M. Sung, said:

The appointment of Robert Millman to Tauriga’s business advisory board is a meaningful addition to the Company at this time. Mr. Millman has co-founded and built several leading biotechnology companies using his considerable skill in identifying potentially revolutionary technology and in negotiating key license agreements. Moreover, he was one of the leading patent lawyers in the early days of the genomics revolution. I believe these skills and experiences are absolutely applicable to the significant market opportunities in the natural medicine sector. The Company continues to make significant progress on a number of fronts and will work closely with Mr. Millman to build its long term fundamentals.

Click here to read the full Tauriga Sciences Inc. (OTCQB:TAUG) press release.